» Articles » PMID: 8840307

A Deficit of Calcitriol Synthesis May Not Be the Initial Factor in the Pathogenesis of Secondary Hyperparathyroidism

Overview
Date 1996 Jan 1
PMID 8840307
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Secondary hyperparathyroidism (HPT) develops early in chronic renal failure (CRF) at a time when plasma calcitriol levels are normal. At this time, PTH are higher than normal controls and serum phosphorous levels are lower. A decrement in total serum Ca is noted, after an oral phosphate load, only in patients with ERF. These data suggest that factors, other than a decrease in calcitriol synthesis, may be involved in the pathogenesis of HPT. A hypothesis is forwarded suggesting that an alteration in the newly cloned calcium sensor receptor may be the earliest abnormality in the HPT, preceding a decrease in plasma calcitriol levels.

Citing Articles

Role of vitamin D in the pathogenesis of atheromatosis.

Rimondi E, Marcuzzi A, Casciano F, Tornese G, Pellati A, Toffoli B Nutr Metab Cardiovasc Dis. 2021; 31(1):344-353.

PMID: 33500110 PMC: 7486169. DOI: 10.1016/j.numecd.2020.08.031.


Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.

Phelps K Nutrients. 2017; 9(5).

PMID: 28445401 PMC: 5452157. DOI: 10.3390/nu9050427.


Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis.

Weng C, Hu C, Yen T, Huang W Ther Clin Risk Manag. 2015; 11:1401-8.

PMID: 26396525 PMC: 4577264. DOI: 10.2147/TCRM.S91475.


Relationship of 1,25 dihydroxy Vitamin D Levels to Clinical Outcomes in Critically Ill Patients with Acute Kidney Injury.

Vijayan A, Li T, Dusso A, Jain S, Coyne D J Nephrol Ther. 2015; 5(1).

PMID: 26295008 PMC: 4540223. DOI: 10.4172/2161-0959.1000190.


Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype.

Kusunoki Y, Matsui I, Hamano T, Shimomura A, Mori D, Yonemoto S Kidney Int. 2015; 88(5):1013-29.

PMID: 26176830 DOI: 10.1038/ki.2015.210.